Versant Venture Capital VII, L.P. - Insider Trading & Ownership

Entity
Company
Location
One Sansome Street, Suite 1650, San Francisco, CA
Summary
The estimated value of insider holdings of Versant Venture Capital VII, L.P. is at least $120M dollars as of March 25, 2024. Versant Venture Capital VII, L.P. is the 10%+ Owner of CHINOOK THERAPEUTICS, INC. and owns shares of CHINOOK THERAPEUTICS, INC. stock worth about $114M. Versant Venture Capital VII, L.P. is the 10%+ Owner of LENZ Therapeutics, Inc. and owns shares of LENZ Therapeutics, Inc. (LENZ) stock worth about $6.52M.
All Insider Reports
All Insider Reports

Ownership of Versant Venture Capital VII, L.P.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
KDNY CHINOOK THERAPEUTICS, INC. 10%+ Owner $114M Apr 4, 2022
LENZ LENZ Therapeutics, Inc. 10%+ Owner $6.52M Mar 21, 2024

Insider Transactions Reported by Versant Venture Capital VII, L.P.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.